As Stanford (Calif.) Medicine continues its research into genomics and personalized medicine, it is leveraging the support of Google Genomics along the way.
Stanford Medicine's Clinical Genomics Service is scheduled to launch this fall, and the program will use Google's cloud computing service Google Genomics to store and analyze its genomic datasets.
The health system plans to use the data to improve and target cancer treatments for patients and diagnose rare, genetic-caused diseases in children. It also seeks to use the analysis for more preventative medicine, according to Lloyd Minor, MD, dean of Stanford Medicine.
"We want to be seen as leaders in determining how genomic data, when combined with other data, is able to predict when we're more prone to developing the disease," he told Fast Company.
Not only will Google's platform enable Stanford clinicians, scientists and researchers, but Google plans to continuously build new generations of genome analysis tools and platforms.
"We anticipate that our contributions of HIPAA-compliant cloud computing, machine learning and data science — combined with Stanford's expertise in genomics and healthcare — could lead to important advances in precision health, a predictive and preventive approach to healthcare," reads the Google announcement of the partnership.
More articles on genomics:
Carnegie Mellon University develops algorithm for cancer genome analysis
Viewpoint: Privatized data contributes to health inequities, slow scientific progress
Watson's data capabilities to help VA personalize cancer care for 10,000 veterans